# EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -

> **NCT04687124** · PHASE4 · UNKNOWN · sponsor: **Jens Rikardt Andersen** · enrollment: 26 (estimated)

## Conditions studied

- Abdominal Cancer
- Radiotherapy; Complications
- Weight Loss
- Energy Supply
- Protein Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** Fish oil
- **OTHER:** standard care

## Key facts

- **NCT ID:** NCT04687124
- **Lead sponsor:** Jens Rikardt Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-15
- **Primary completion:** 2021-01
- **Final completion:** 2021-02
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2020-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04687124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04687124, "EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04687124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*